Bridgeway Capital Management’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,922
| Closed | -$105K | – | 1385 |
|
|
2023
Q4 | $105K | Hold |
3,922
| – | – | ﹤0.01% | 1231 |
|
|
2023
Q3 | $237K | Buy |
+3,922
| New | +$237K | 0.01% | 1064 |
|
|
2018
Q4 | – | Sell |
-278
| Closed | -$240K | – | 1476 |
|
|
2018
Q3 | $240K | Sell |
278
-278
| -50% | -$240K | ﹤0.01% | 1289 |
|
|
2018
Q2 | $383K | Sell |
556
-972
| -64% | -$670K | ﹤0.01% | 1201 |
|
|
2018
Q1 | $681K | Hold |
1,528
| – | – | 0.01% | 987 |
|
|
2017
Q4 | $673K | Hold |
1,528
| – | – | 0.01% | 997 |
|
|
2017
Q3 | $753K | Sell |
1,528
-694
| -31% | -$342K | 0.01% | 951 |
|
|
2017
Q2 | $1.23M | Sell |
2,222
-1,763
| -44% | -$977K | 0.01% | 746 |
|
|
2017
Q1 | $2.64M | Hold |
3,985
| – | – | 0.03% | 475 |
|
|
2016
Q4 | $1.33M | Sell |
3,985
-1,894
| -32% | -$634K | 0.02% | 696 |
|
|
2016
Q3 | $1.77M | Buy |
5,879
+2,222
| +61% | +$668K | 0.03% | 572 |
|
|
2016
Q2 | $633K | Buy |
3,657
+2,022
| +124% | +$350K | 0.01% | 946 |
|
|
2016
Q1 | $366K | Sell |
1,635
-409
| -20% | -$91.6K | 0.01% | 1159 |
|
|
2015
Q4 | $1.24M | Hold |
2,044
| – | – | 0.02% | 660 |
|
|
2015
Q3 | $1.05M | Hold |
2,044
| – | – | 0.02% | 727 |
|
|
2015
Q2 | $894K | Buy |
2,044
+409
| +25% | +$179K | 0.02% | 837 |
|
|
2015
Q1 | $592K | Buy |
1,635
+663
| +68% | +$240K | 0.01% | 1013 |
|
|
2014
Q4 | $349K | Buy |
+972
| New | +$349K | 0.01% | 1181 |
|